Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

VEGF

Corautus Genetics (VEGF)

Corautus Genetics (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:VEGF
DatumZeitQuelleÜberschriftSymbolFirma
05/06/200701h04PR Newswire (US)Corautus Genetics Stockholders Approve Merger with VIA Pharmaceuticals and Related ProposalsNASDAQ:VEGFCorautus Genetics (MM)
29/05/200722h00PR Newswire (US)Corautus Genetics Receives Nasdaq Additional Deficiency NoticeNASDAQ:VEGFCorautus Genetics (MM)
08/02/200714h00PR Newswire (US)Corautus Genetics and VIA Pharmaceuticals Announce Merger AgreementNASDAQ:VEGFCorautus Genetics (MM)
17/01/200718h30PR Newswire (US)Corautus Announces DiscussionsNASDAQ:VEGFCorautus Genetics (MM)
14/12/200622h00PR Newswire (US)Corautus Genetics Inc. Receives Determination Letter from Nasdaq Regarding Continued ListingNASDAQ:VEGFCorautus Genetics (MM)
14/11/200614h00PR Newswire (US)Corautus Genetics Reports Third Quarter Financial ResultsNASDAQ:VEGFCorautus Genetics (MM)
07/11/200621h00PR Newswire (US)Corautus Genetics Inc. to Host Conference Call on November 14, 2006NASDAQ:VEGFCorautus Genetics (MM)
03/11/200622h10PR Newswire (US)Corautus Genetics Announces Redirection of Focus and Transition Of OfficersNASDAQ:VEGFCorautus Genetics (MM)
10/10/200615h00PR Newswire (US)Corautus Genetics Announces Final Efficacy Results of GENASIS Phase IIb Clinical TrialNASDAQ:VEGFCorautus Genetics (MM)
10/08/200614h58PR Newswire (US)Corautus Genetics Reports Second Quarter Financial ResultsNASDAQ:VEGFCorautus Genetics (MM)
08/08/200615h00PR Newswire (US)Corautus Genetics Inc. to Host Conference Call on August 10, 2006NASDAQ:VEGFCorautus Genetics (MM)
13/07/200614h58PR Newswire (US)Corautus Genetics Announces Partial Lifting of FDA Clinical Hold and Update on GENASIS Database LockNASDAQ:VEGFCorautus Genetics (MM)
06/07/200615h00PR Newswire (US)Corautus Genetics Announces Conversion of Boston Scientific Debt Into EquityNASDAQ:VEGFCorautus Genetics (MM)
20/06/200615h15PR Newswire (US)Corautus Genetics to Present at Jefferies Life Sciences ConferenceNASDAQ:VEGFCorautus Genetics (MM)
31/05/200614h58PR Newswire (US)Corautus Genetics Announces Filing of Response to FDA Clinical HoldNASDAQ:VEGFCorautus Genetics (MM)
26/05/200619h00PR Newswire (US)Corautus Genetics Receives NASDAQ Deficiency Notice Related to Minimum Bid PriceNASDAQ:VEGFCorautus Genetics (MM)
15/05/200615h00PR Newswire (US)Corautus Genetics Reports an Update of its Therapeutic Development Program and First Quarter Financial ResultsNASDAQ:VEGFCorautus Genetics (MM)
08/05/200615h00PR Newswire (US)Corautus Genetics Inc. to Host Conference Call on May 15, 2006NASDAQ:VEGFCorautus Genetics (MM)
19/04/200615h00PR Newswire (US)Corautus Genetics Inc. Names Todd Stallings as Vice President - Clinical OperationsNASDAQ:VEGFCorautus Genetics (MM)
10/04/200614h45PR Newswire (US)Corautus Announces Termination of Patient Enrollment in GENASIS Severe Angina Clinical TrialNASDAQ:VEGFCorautus Genetics (MM)
04/04/200616h00PR Newswire (US)Corautus Genetics Inc. to Present at BIO 2006 Business ForumNASDAQ:VEGFCorautus Genetics (MM)
20/03/200614h00PR Newswire (US)Corautus Genetics Reports Fourth Quarter and 2005 Financial Results and Provides Update on Temporary Suspension of GENASIS TriaNASDAQ:VEGFCorautus Genetics (MM)
14/03/200614h31PR Newswire (US)Corautus Genetics Inc. Announces Developments in Clinical Trial and Public OfferingNASDAQ:VEGFCorautus Genetics (MM)
10/03/200614h06PR Newswire (US)Corautus Genetics Inc. Announces Pricing of Equity OfferingNASDAQ:VEGFCorautus Genetics (MM)
24/02/200622h42PR Newswire (US)Corautus Genetics Announces Proposed Public Offering of Common StockNASDAQ:VEGFCorautus Genetics (MM)
23/02/200614h00PR Newswire (US)Corautus Genetics Announces Update on GENASIS TrialNASDAQ:VEGFCorautus Genetics (MM)
26/01/200614h00PR Newswire (US)Corautus Genetics' Phase IIb Clinical Trial for Severe Angina Treatment Receives Go-Ahead from Data Safety Monitoring CommitteeNASDAQ:VEGFCorautus Genetics (MM)
11/01/200614h00PR Newswire (US)Corautus Genetics Announces Collaboration for Phase I Trial for the Treatment of Critical Limb Ischemia with VEGF-2NASDAQ:VEGFCorautus Genetics (MM)
10/11/200514h00PR Newswire (US)Corautus Genetics Reports Third Quarter ResultsNASDAQ:VEGFCorautus Genetics (MM)
03/11/200514h02PR Newswire (US)Corautus Genetics Receives FDA Fast Track Designation for VEGF-2NASDAQ:VEGFCorautus Genetics (MM)
 Showing the most relevant articles for your search:NASDAQ:VEGF